# Long Term Study With B2036-PEG

> **NCT00143416** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 16 (—)

## Conditions studied

- Acromegaly

## Interventions

- **DRUG:** Pegvisomant

## Key facts

- **NCT ID:** NCT00143416
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 16 (—)
- **Last updated:** 2008-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143416, "Long Term Study With B2036-PEG". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00143416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*